International Cooperation Thwarts Massive Fentanyl Precursor Shipment

A collaborative effort between international authorities has successfully intercepted three tons of 1-boc-4-piperidone, a key chemical used in the illicit manufacture of fentanyl. The seizure, highlighted in the International Narcotics Control Board’s (INCB) 2025 Annual Report, prevented the potential production of an estimated 1.4 to 3.3 tons of fentanyl – equivalent to 700 million to 1.6 billion lethal doses of the drug.

The Interception and its Impact

The intercepted shipment, which occurred in March 2025, demonstrates the vital role of international cooperation in combating the evolving illegal drug trade. The INCB utilizes a pre-export notification platform, allowing authorities to track and intercept diverted precursor chemicals before they reach illicit manufacturers.

The Role of the INCB

The International Narcotics Control Board (INCB) is an independent, quasi-judicial body tasked with monitoring the implementation of international drug control conventions adopted in 1961, 1971, and 1988. These conventions form the foundation of the global drug control system. The INCB relies on data provided by governments regarding the cultivation, manufacture, and trade of controlled substances, ensuring their availability for legitimate medical and scientific purposes.

According to the INCB, this system has maintained a “very low” rate of diversion of legitimately produced narcotic drugs into illicit markets and has “virtually stopped” the diversion of psychotropic substances.

In 2025 alone, over 190 countries and territories collaborated through the INCB’s online pre-export notification (PEN) platform, monitoring more than 34,000 planned shipments of internationally controlled drug precursors.

New Threats and Shifting Markets

Despite these successes, the INCB warns that drug trafficking networks are rapidly adapting. Cocaine trafficking remains the fastest-growing illicit drug market, fueled by increased production in South America and expansion into Asia, and Africa.

In Europe, cocaine trafficking to Western and Central Europe has “dramatically increased,” whereas the illicit manufacture of synthetic drugs continues to expand.

In North America, synthetic drug overdoses decreased by 17% in Canada and 27% in the United States, but the Board cautioned against interpreting this as a sustained trend.

Africa faces a growing concern with the trafficking of pharmaceutical opioids, including substandard products. The South Asian region accounts for one-third of the world’s estimated opioid users. Methamphetamine remains the primary synthetic drug threat in East and Southeast Asia, with record seizures reported.

Access to Pain Relief Remains Unequal

The INCB also highlighted persistent inequalities in access to pain relief medicines, particularly in low- and middle-income countries. Many nations continue to struggle with procuring medications containing morphine, and increasing the availability and affordability of psychotropic substances remains a priority.

“Protecting the health of people around the world from the dangers of illicit drugs is a common and shared responsibility,” said Board President Professor Sevil Atasoy. “The international drug control system relies on the willingness and capacity of countries to work together.”

Recent International Scheduling of Fentanyl Precursors

In March 2024, the United Nations Commission on Narcotic Drugs (CND) unanimously agreed to schedule 4-piperidone and 1-boc-4-piperidone under international control, following a recommendation from the INCB. This decision, made under the 1988 Convention, aims to strengthen law enforcement efforts against fentanyl and other synthetic drug trafficking.

The CND also agreed to place 16 additional substances used in the illicit manufacture of methamphetamine and MDMA under international control. The World Health Organization (WHO) recommended adding the synthetic opioid butonitazene to the 1961 Convention and four additional substances to the schedules of the 1971 Convention.

The U.S. Department of State had designated 4-piperidone as a List I chemical in September 2022, recognizing its role in the illicit fentanyl market.